Luque, M; Matic, M; Heras-Garvin, A; Amo-Aparicio, J; Luk, KC; Haindl, MT; Khalil, M; Skouras, DB; Dinarello, CA; Stefanova, N.
Clinically advanced NLRP3 inhibitor modulates microglial transcriptome and alleviates α-synuclein-induced progression of parkinsonism.
J Neuroinflammation. 2026;
Doi: 10.1186/s12974-026-03716-3
PubMed
FullText
FullText_MUG